OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer: a ctDNA-guided phase II randomised approach. Study protocol

Louise Bach Callesen*, Torben Frøstrup Hansen, Rikke Fredslund Andersen, Niels Pallisgaard, Stine Kramer, Sven Schlander, Søren Rafael Rafaelsen, Anders Kindberg Boysen, Lars Henrik Jensen, Anders Jakobsen, Karen Lise Garm Spindler

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

Original languageEnglish
JournalActa Oncologica
Issue number9
Pages (from-to)1152-1156
Publication statusPublished - Sept 2022


  • Circulating Tumor DNA
  • Clinical Trials, Phase II as Topic
  • Colorectal Neoplasms/drug therapy
  • Follow-Up Studies
  • Humans
  • Patient Selection

Cite this